CLARIVATE PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.7 USD | +1.42% |
|
-2.40% | -38.44% |
| 05-31 | Clarivate Partners With HealthWise Data to Enhance Patient Insights | MT |
| 05-21 | The latest transactions by star managers |  |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 2.61B 205B | Sales 2025 * | 2.67B 210B | Capitalization | 3.81B 299B |
|---|---|---|---|---|---|
| Net income 2024 * | -93M -7.3B | Net income 2025 * | 14M 1.1B | EV / Sales 2024 * | 3.31 x |
| Net Debt 2024 * | 4.83B 379B | Net Debt 2025 * | 4.33B 340B | EV / Sales 2025 * | 3.04 x |
| P/E ratio 2024 * |
-38.4
x | P/E ratio 2025 * |
363
x | Employees | 12,000 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.15% |
More Fundamentals
* Assessed data
More news
Latest transcript on Clarivate Plc
More recommendations
More press releases
| 1 day | +1.42% | ||
| 1 week | -2.40% | ||
| 1 month | -17.87% | ||
| 3 months | -20.17% | ||
| 6 months | -29.02% | ||
| Current year | -38.44% |
1 week
5.52
5.93
1 month
5.527.30
Current year
5.529.61
1 year
5.5210.03
3 years
5.5234.79
5 years
5.5234.79
10 years
5.5234.79
| Managers | Title | Age | Since |
|---|---|---|---|
Jonathan Gear
CEO | Chief Executive Officer | 53 | 10/07/22 |
Jonathan Collins
DFI | Director of Finance/CFO | 44 | 15/12/21 |
William Graff
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jerre Stead
BRD | Director/Board Member | 81 | 30/04/19 |
Anthony Munk
BRD | Director/Board Member | 63 | 30/09/16 |
Richard Roedel
BRD | Director/Board Member | 74 | 06/05/20 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 12.89% | 254 M€ | +13.69% | - | |
| 0.71% | 14 M€ | +3.72% | ||
| 0.67% | 3 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/05/24 | 5.7 | +1.42% | 7,245,804 |
| 30/05/24 | 5.62 | -0.18% | 8,397,665 |
| 29/05/24 | 5.63 | -4.74% | 4,075,569 |
| 28/05/24 | 5.91 | +1.20% | 4,036,379 |
Delayed Quote Nyse, May 31, 2024 at 09:00 pm
More quotes
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It serves a large, diverse, and global customer base across the scientific research, intellectual property, and life sciences and healthcare end markets. Its customers include corporations, universities, law firms, and others.
Calendar
04/06/2024
- William Blair Growth Stock Conference
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
5.7
USD
Average target price
7.93
USD
Spread / Average Target
+39.12%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -38.44% | 3.81B | |
| +21.07% | 77.46B | |
| -12.46% | 39.23B | |
| +13.48% | 37.74B | |
| -6.43% | 28.6B | |
| -15.26% | 15.41B | |
| +4.67% | 13.97B | |
| +10.00% | 10.44B | |
| -18.03% | 4.25B | |
| +19.10% | 2.32B |
- Stock Market
- Equities
- CLVT Stock
